| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 13 | 2020 | 5061 | 0.780 |
Why?
|
| Carcinoma, Ductal | 1 | 2016 | 145 | 0.500 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2008 | 673 | 0.480 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 677 | 0.430 |
Why?
|
| Protein Kinase C | 3 | 2008 | 396 | 0.410 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 52 | 0.400 |
Why?
|
| Isoenzymes | 3 | 2008 | 614 | 0.400 |
Why?
|
| Carcinoma, Pancreatic Ductal | 7 | 2019 | 1724 | 0.390 |
Why?
|
| Lymphocyte Activation | 5 | 2020 | 1688 | 0.380 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 365 | 0.370 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 973 | 0.370 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 1130 | 0.370 |
Why?
|
| Metabolomics | 1 | 2013 | 478 | 0.360 |
Why?
|
| Tretinoin | 1 | 2011 | 623 | 0.340 |
Why?
|
| Interleukin-17 | 2 | 2020 | 250 | 0.310 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 1439 | 0.210 |
Why?
|
| 5-Methylcytosine | 2 | 2019 | 56 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2020 | 11965 | 0.190 |
Why?
|
| Extracellular Traps | 1 | 2020 | 25 | 0.190 |
Why?
|
| Lactic Acid | 2 | 2019 | 305 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 52 | 0.170 |
Why?
|
| Mitochondrial Dynamics | 1 | 2019 | 62 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 323 | 0.170 |
Why?
|
| Isoquinolines | 1 | 2019 | 116 | 0.170 |
Why?
|
| Radiation-Protective Agents | 1 | 2019 | 128 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2018 | 43 | 0.160 |
Why?
|
| Chromogranins | 1 | 2018 | 84 | 0.160 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2019 | 107 | 0.160 |
Why?
|
| Curcumin | 2 | 2016 | 117 | 0.160 |
Why?
|
| Adenocarcinoma in Situ | 1 | 2018 | 31 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8873 | 0.160 |
Why?
|
| Animals | 18 | 2020 | 59536 | 0.150 |
Why?
|
| Calcineurin | 2 | 2008 | 128 | 0.150 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 108 | 0.150 |
Why?
|
| Tumor Microenvironment | 3 | 2020 | 2864 | 0.150 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 189 | 0.150 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 1399 | 0.150 |
Why?
|
| Glycine | 1 | 2019 | 289 | 0.150 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 220 | 0.150 |
Why?
|
| Gene Editing | 1 | 2019 | 216 | 0.140 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 613 | 0.140 |
Why?
|
| Oncogenes | 1 | 2019 | 673 | 0.140 |
Why?
|
| Mice | 14 | 2019 | 34495 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 750 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1331 | 0.130 |
Why?
|
| Protein Kinase C-theta | 3 | 2008 | 11 | 0.120 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 10331 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 651 | 0.120 |
Why?
|
| Neoplasms | 3 | 2016 | 15193 | 0.120 |
Why?
|
| Mitochondria | 2 | 2019 | 1282 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 2 | 2008 | 778 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2008 | 1146 | 0.110 |
Why?
|
| Exosomes | 1 | 2016 | 253 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 461 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2018 | 1152 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2015 | 470 | 0.100 |
Why?
|
| Cell Line, Tumor | 8 | 2020 | 14551 | 0.100 |
Why?
|
| Triazoles | 1 | 2016 | 617 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2008 | 1033 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1824 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 810 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2019 | 1411 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 702 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 624 | 0.090 |
Why?
|
| Metabolome | 1 | 2013 | 344 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2019 | 5710 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 3821 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1443 | 0.090 |
Why?
|
| Glucose | 1 | 2016 | 1248 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2019 | 7226 | 0.090 |
Why?
|
| bcl-X Protein | 2 | 2008 | 196 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1165 | 0.090 |
Why?
|
| Computational Biology | 1 | 2015 | 1271 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2016 | 1682 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2011 | 1008 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 726 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 5178 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2019 | 5270 | 0.080 |
Why?
|
| NFATC Transcription Factors | 1 | 2008 | 96 | 0.080 |
Why?
|
| Apoptosis | 5 | 2019 | 7591 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1217 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2012 | 554 | 0.080 |
Why?
|
| Cell Survival | 3 | 2008 | 3045 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2012 | 4307 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 294 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 1586 | 0.070 |
Why?
|
| Complementarity Determining Regions | 1 | 2006 | 43 | 0.070 |
Why?
|
| Graves Disease | 1 | 2006 | 50 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2019 | 2669 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 3101 | 0.070 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 253 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 610 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2008 | 403 | 0.070 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 247 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2011 | 3536 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 2508 | 0.070 |
Why?
|
| Cell Communication | 1 | 2008 | 509 | 0.060 |
Why?
|
| Doxorubicin | 1 | 2012 | 3005 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 6942 | 0.060 |
Why?
|
| Humans | 16 | 2020 | 261506 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 5395 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 5159 | 0.060 |
Why?
|
| Cell Movement | 1 | 2011 | 2466 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 1489 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2006 | 576 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 6150 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 14289 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 1265 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 4143 | 0.050 |
Why?
|
| Ketoglutaric Acids | 1 | 2019 | 38 | 0.050 |
Why?
|
| Wnt-5a Protein | 1 | 2019 | 45 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2006 | 2450 | 0.040 |
Why?
|
| Dynamins | 1 | 2019 | 74 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2019 | 51 | 0.040 |
Why?
|
| Disease Progression | 3 | 2018 | 6682 | 0.040 |
Why?
|
| Cytokines | 1 | 2008 | 2809 | 0.040 |
Why?
|
| Octamer Transcription Factors | 1 | 2018 | 19 | 0.040 |
Why?
|
| Mutation | 1 | 2018 | 15179 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2006 | 2086 | 0.040 |
Why?
|
| Dependovirus | 1 | 2019 | 135 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 97 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 91 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2018 | 103 | 0.040 |
Why?
|
| Patient-Specific Modeling | 1 | 2017 | 28 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 269 | 0.040 |
Why?
|
| Pancreatitis, Chronic | 1 | 2018 | 116 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 336 | 0.040 |
Why?
|
| Click Chemistry | 1 | 2016 | 9 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2016 | 1493 | 0.030 |
Why?
|
| Fermentation | 1 | 2016 | 60 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 259 | 0.030 |
Why?
|
| Neutrophils | 1 | 2020 | 835 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 133 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2016 | 195 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 716 | 0.030 |
Why?
|
| Lentivirus | 1 | 2016 | 169 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 367 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2019 | 825 | 0.030 |
Why?
|
| Cell Shape | 1 | 2015 | 128 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2016 | 274 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 278 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 508 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2016 | 566 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 1519 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 1048 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 395 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 541 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2019 | 1694 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 3869 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 769 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 519 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 492 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 1879 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3981 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 3033 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1859 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2074 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2018 | 2218 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 703 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2359 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 1466 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2216 | 0.020 |
Why?
|
| Glutathione | 1 | 2012 | 368 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2016 | 1026 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 2045 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 3438 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2006 | 1549 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 2265 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2054 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1954 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2008 | 95 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2008 | 170 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2008 | 170 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 2016 | 5767 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 3254 | 0.020 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2006 | 9 | 0.020 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2006 | 38 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 3552 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2006 | 119 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2008 | 185 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 634 | 0.020 |
Why?
|
| Thyroxine | 1 | 2006 | 116 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7222 | 0.020 |
Why?
|
| Male | 4 | 2019 | 123000 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12221 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2006 | 266 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2006 | 311 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 6009 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5112 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2006 | 246 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2006 | 257 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 471 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2006 | 250 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 798 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 661 | 0.010 |
Why?
|
| Female | 3 | 2019 | 141928 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 15694 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 2138 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 3203 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 5114 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 2488 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 5637 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 7789 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 21445 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 29902 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 70117 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 77950 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 86204 | 0.010 |
Why?
|